GenEng News  Jul 5  Comment 
Cannabinoid-based drug developer Zynerba Pharmaceuticals said today it will halt development of its D-glyceric acid ester-delta-9-tetrahydrocannabinol (THC) prodrug candidate ZYN001 following its failure in a clinical trial, and instead refocus...
Benzinga  Jun 29  Comment 
Tenet Healthcare Corp (NYSE: THC) shares are up 128 percent year-to-date, reflecting cost-cutting efforts and earnings stabilization. But given the firm’s gains in top-line growth and multiple expansion, Jefferies expects the rally to come to an...
Benzinga  Jun 27  Comment 
Two trends — sparkling water and recreational cannabis — are joining forces forces in a new beverage. What Happened Heineken N.V. (ADR) (OTC: HEINY)-owned Lagunitas Brewing company will debut a THC-infused sparkling water beverage, Hi-Fi...
TechCrunch  Jun 25  Comment 
In a news release today, the FDA announced its approval of a marijuana-derived drug called Epidiolex for the treatment of seizures in a subset of patients suffering from severe epilepsy. Epidiolex contains CBD, a cannabis chemical compound...
MarketWatch  Jun 25  Comment 
The first cannabis-derived drug has been approved by the Food and Drug Administration. The drug, epidiolex, is intended for seizures associated with two rare types of childhood epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. Epidiolex...
Yahoo  Apr 22  Comment 
Are these the most anti-marijuana states in America?
Benzinga  Mar 15  Comment 
Pete Najarian recommended on CNBC's "Fast Money Final Trade" a long position in International Business Machines Corp. (NYSE: IBM). Tim Seymour would buy JPMorgan Chase & Co. (NYSE: JPM). Karen Finerman wants to buy the weakness in Lowe's...
Motley Fool  Feb 27  Comment 
Find out how these stocks bucked a tough market.


I truly wanted to cscrtount a quick comment in order to thank you for those lovely techniques you are sharing on this site. My considerable internet search has finally been recognized with reasonable points to share with my good friends. I d assert that many of us website visitors are definitely blessed to be in a superb network with many wonderful people with good methods. I feel pretty happy to have used your entire web page and look forward to many more enjoyable minutes reading here. Thank you once again for a lot of things.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki